{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:58:01Z","timestamp":1774778281644,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.toxrep.2017.12.010","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T21:30:50Z","timestamp":1515447050000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Application of mutagen sensitivity assay in a glioma case-control study"],"prefix":"10.1016","volume":"5","author":[{"given":"Serap","family":"Erdal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Gurule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Berwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnna","family":"Shimek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Il\u2019yasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Ali-Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darell D.","family":"Bigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis N.","family":"Leyba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten A.M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.toxrep.2017.12.010_bib0005","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cncr.23741","article-title":"Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium","volume":"113","author":"Bondy","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1667\/RR2186.1","article-title":"Medical diagnostic radiation exposures and risk of gliomas","volume":"175","author":"Davis","year":"2011","journal-title":"Radiat. Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0020","series-title":"Principles and Practice of Neuro-Oncology: A Multidisciplinary Approach","article-title":"Association between exposure to ionizing radiation and gliomas","author":"Sadetzki","year":"2010"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1179\/oeh.2006.12.1.16","article-title":"Work exposures to animal neurocarcinogens","volume":"12","author":"Davis","year":"2006","journal-title":"Int. J. Occup. Environ. Health"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10937400902894152","article-title":"Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiology","volume":"12","author":"Il\u2019yasova","year":"2009","journal-title":"J. Toxicol. Environ. Health Part B"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00008571-199212000-00005","article-title":"Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology","volume":"2","author":"Bartsch","year":"1992","journal-title":"Pharmacogenetics"},{"issue":"Suppl. 3","key":"10.1016\/j.toxrep.2017.12.010_bib0040","first-page":"151","article-title":"Noninvasive methods for measuring DNA alkylation in experimental animals and humans","volume":"101","author":"Shuker","year":"1993","journal-title":"Environ Health Perspect."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0027-5107(90)90110-P","article-title":"The kinetics of DNA damage by bleomycin in mammalian cells","volume":"232","author":"L\u00f3pez-Larraza","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0050","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.dnarep.2004.05.004","article-title":"Alkylation damage in DNA and RNA\u2014repair mechanisms and medical significance","volume":"3","author":"Drabl\u00f8s","year":"2004","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0055","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/tx034108e","article-title":"DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice","volume":"16","author":"Gamboa da Costa","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0060","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/carcin\/16.5.1161","article-title":"Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide","volume":"16","author":"Segerb\u00e4ck","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/tx990040k","article-title":"Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice","volume":"12","author":"Sumner","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0070","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jf020302f","article-title":"Analysis of acrylamide, a carcinogen formed in heated foodstuffs","volume":"50","author":"Tareke","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0075","first-page":"1","article-title":"IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals","volume":"vol. 60","author":"IARC","year":"1994"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0080","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1158\/1055-9965.EPI-08-0995","article-title":"Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls","volume":"18","author":"Il\u2019yasova","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-5223.1983.tb00574.x","article-title":"Genetic instability in the human population: a working hypothesis","volume":"98","author":"Hsu","year":"1983","journal-title":"Hereditas"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910430310","article-title":"Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis","volume":"43","author":"Hsu","year":"1989","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/jnci\/91.13.1097","article-title":"Genetics of smoking-Related cancer and mutagen sensitivity","volume":"91","author":"Caporaso","year":"1999","journal-title":"Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/1541-7786.MCR-05-0196","article-title":"Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes","volume":"4","author":"Cloos","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0105","first-page":"33","article-title":"Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer","volume":"18","author":"Ankathil","year":"1999","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/em.1075","article-title":"Mutagen sensitivity as an indicator of soft tissue sarcoma risk","volume":"38","author":"Berwick","year":"2001","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0115","first-page":"1619","article-title":"Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health","volume":"60","author":"Bonassi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0120","first-page":"713","article-title":"Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma","volume":"9","author":"Cloos","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0125","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/jnci\/91.13.1125","article-title":"Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes","volume":"91","author":"Cloos","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/88.8.530","article-title":"Genetic susceptibility to head and neck squamous cell carcinoma","volume":"88","author":"Cloos","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/mutage\/gel030","article-title":"Reliability of mutagen sensitivity assay: an inter-laboratory comparison","volume":"21","author":"Erdei","year":"2006","journal-title":"Mutagenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0140","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1158\/0008-5472.CAN-03-3360","article-title":"Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts","volume":"64","author":"Hagmar","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0145","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jnci\/86.22.1660","article-title":"Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis","volume":"86","author":"Olden","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0150","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jnci\/86.22.1681","article-title":"Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract","volume":"86","author":"Spitz","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0155","first-page":"2813","article-title":"Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions","volume":"62","author":"Wu","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/carcin\/24.2.269","article-title":"Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls","volume":"24","author":"Zheng","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(02)00513-7","article-title":"Genetic instability of specific chromosomes associated with a family history of cancer","volume":"136","author":"Zhu","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.mrrev.2003.10.002","article-title":"Mutagen sensitivity assays in population studies","volume":"544","author":"Au","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0175","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/jnci\/93.20.1553","article-title":"Radiation sensitivity and risk of glioma","volume":"93","author":"Bondy","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mrgentox.2006.09.007","article-title":"Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms","volume":"626","author":"Chanvaivit","year":"2007","journal-title":"Mutat. Res. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10238-008-0171-1","article-title":"Susceptibility of peripheral lymphocytes of brain tumour patients to in vitro radiation-induced DNA damage, a preliminary study","volume":"8","author":"Kalthur","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0190","first-page":"1484","article-title":"Mutagen sensitivity and risk of gliomas: a case-control analysis","volume":"56","author":"Bondy","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1383-5718(00)00154-6","article-title":"Risk assessment for developing gliomas: a comparison of two cytogenetic approaches","volume":"490","author":"El-Zein","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0200","first-page":"3031","article-title":"Gamma-ray mutagen sensitivity and survival in patients with glioma","volume":"4","author":"Sigurdson","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0205","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/carcin\/bgq141","article-title":"Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk","volume":"31","author":"Liu","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1055-9965.EPI-10-0948","article-title":"Assessment of type of allergy and antihistamine use in the development of glioma","volume":"20","author":"McCarthy","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0215","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1055-9965.EPI-08-0304","article-title":"Comparing the reliability of responses to telephone-administered versus self-administered web-based surveys in a case-control study of adult malignant brain cancer","volume":"17","author":"Rankin","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/mutage\/16.1.25","article-title":"Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes","volume":"16","author":"Schmezer","year":"2001","journal-title":"Mutagenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuro.2004.01.004","article-title":"The changing view of acrylamide neurotoxicity","volume":"25","author":"LoPachin","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0230","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ijc.24126","article-title":"DNA repair phenotype and cancer susceptibility\u2013a mini review","volume":"124","author":"Li","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jnci\/92.11.874","article-title":"Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review","volume":"92","author":"Berwick","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0240","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/carcin\/bgq141","article-title":"Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk","volume":"31","author":"Liu","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0245","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/88.19.1346","article-title":"DNA repair: enzymatic mechanisms and relevance to drug response","volume":"88","author":"Chaney","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0250","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0277-5379(86)90375-5","article-title":"Impaired DNA-repair synthesis in lymphocytes of breast cancer patients","volume":"22","author":"Kovacs","year":"1986","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.toxrep.2017.12.010_bib0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/carcin\/bgm006","article-title":"A review of mechanisms of acrylamide carcinogenicity","volume":"28","author":"Besaratinia","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxrep.2017.12.010_bib0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3835(01)00400-1","article-title":"Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies","volume":"166","author":"Cheng","year":"2001","journal-title":"Cancer Lett."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750017301178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750017301178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:45:41Z","timestamp":1762011941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750017301178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":52,"alternative-id":["S2214750017301178"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2017.12.010","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of mutagen sensitivity assay in a glioma case-control study","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2017.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}